Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,480 | -5,611 | -15,880 | -11,650 | -8,015 |
| Depreciation Amortization | 69 | 34 | 120 | 92 | 58 |
| Accounts payable and accrued liabilities | 652 | 376 | N/A | -85 | -78 |
| Other Working Capital | 652 | 216 | -390 | -304 | -114 |
| Other Operating Activity | -206 | -172 | 650 | 414 | 251 |
| Operating Cash Flow | $-11,313 | $-5,157 | $-15,500 | $-11,533 | $-7,898 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -120 | -121 | -87 |
| Investing Cash Flow | $N/A | $0 | $-120 | $-121 | $-87 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32 | 30 | N/A | 9 | 7 |
| Other Financing Activity | 28,557 | 5,500 | 9,500 | 7,000 | 4,500 |
| Financing Cash Flow | $28,589 | $5,530 | $9,500 | $7,009 | $4,507 |
| Beginning Cash Position | 391 | 391 | 6,510 | 6,512 | 6,512 |
| End Cash Position | 17,667 | 764 | 390 | 1,867 | 3,034 |
| Net Cash Flow | $17,276 | $373 | $-6,120 | $-4,645 | $-3,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,313 | -5,157 | -15,500 | -11,533 | -7,898 |
| Capital Expenditure | N/A | 0 | N/A | -121 | -87 |
| Free Cash Flow | -11,313 | -5,157 | -15,500 | -11,654 | -7,985 |